Literature DB >> 21142913

Conference scene: pediatric pharmacogenomics and personalized medicine.

J Steven Leeder, John Lantos, Stephen P Spielberg.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 21142913      PMCID： PMC4610716          DOI： 10.2217/pgs.10.175

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN： 1462-2416            Impact factor:   2.533


× No keyword cloud information.
  8 in total

1.  Development of a large-scale de-identified DNA biobank to enable personalized medicine.

Authors:  D M Roden; J M Pulley; M A Basford; G R Bernard; E W Clayton; J R Balser; D R Masys
Journal:  Clin Pharmacol Ther       Date:  2008-05-21       Impact factor: 6.875

2.  Understanding the relative roles of pharmacogenetics and ontogeny in pediatric drug development and regulatory science.

Authors:  J Steven Leeder; Gregory L Kearns; Stephen P Spielberg; John van den Anker
Journal:  J Clin Pharmacol       Date:  2010-02-11       Impact factor: 3.126

3.  Germline genetic variation in an organic anion transporter polypeptide associated with methotrexate pharmacokinetics and clinical effects.

Authors:  Lisa R Treviño; Noriko Shimasaki; Wenjian Yang; John C Panetta; Cheng Cheng; Deqing Pei; Diana Chan; Alex Sparreboom; Kathleen M Giacomini; Ching-Hon Pui; William E Evans; Mary V Relling
Journal:  J Clin Oncol       Date:  2009-11-09       Impact factor: 44.544

4.  Network-based elucidation of human disease similarities reveals common functional modules enriched for pluripotent drug targets.

Authors:  Silpa Suthram; Joel T Dudley; Annie P Chiang; Rong Chen; Trevor J Hastie; Atul J Butte
Journal:  PLoS Comput Biol       Date:  2010-02-05       Impact factor: 4.475

5.  Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy.

Authors:  Colin J D Ross; Hagit Katzov-Eckert; Marie-Pierre Dubé; Beth Brooks; S Rod Rassekh; Amina Barhdadi; Yassamin Feroz-Zada; Henk Visscher; Andrew M K Brown; Michael J Rieder; Paul C Rogers; Michael S Phillips; Bruce C Carleton; Michael R Hayden
Journal:  Nat Genet       Date:  2009-11-08       Impact factor: 38.330

6.  Adverse drug reaction active surveillance: developing a national network in Canada's children's hospitals.

Authors:  Bc Carleton; Rl Poole; Ma Smith; Js Leeder; R Ghannadan; Cjd Ross; Ms Phillips; Mr Hayden
Journal:  Pharmacoepidemiol Drug Saf       Date:  2009-08       Impact factor: 2.890

7.  Chronic health conditions in adult survivors of childhood cancer.

Authors:  Kevin C Oeffinger; Ann C Mertens; Charles A Sklar; Toana Kawashima; Melissa M Hudson; Anna T Meadows; Debra L Friedman; Neyssa Marina; Wendy Hobbie; Nina S Kadan-Lottick; Cindy L Schwartz; Wendy Leisenring; Leslie L Robison
Journal:  N Engl J Med       Date:  2006-10-12       Impact factor: 176.079

Review 8.  Fulfilling the promise of personalized medicine? Systematic review and field synopsis of pharmacogenetic studies.

Authors:  Michael V Holmes; Tina Shah; Christine Vickery; Liam Smeeth; Aroon D Hingorani; Juan P Casas
Journal:  PLoS One       Date:  2009-12-02       Impact factor: 3.240
  8 in total
  1 in total

1.  Pharmacogenomics in children: advantages and challenges of next generation sequencing applications.

Authors:  O M Vanakker; A De Paepe
Journal:  Int J Pediatr       Date:  2013-01-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.